Dopamine changes in a rat model of intracerebral hemorrhage

Acta Neurochirurgica, Supplementum

Volumn , Issue 96, 2006, Pages 222-226

  Cannon, J R ^a   Nakamura, T ^a   Keep, R F ^a   Richardson, R J ^a   Hua, Y ^a   Xi, G ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

dopamine; Intracerebral hemorrhage; aminobutyric acid

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE;

ADAPTATION; ANIMAL; ARTICLE; BRAIN HEMORRHAGE; CORPUS STRIATUM; DISEASE MODEL; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CEREBRAL HEMORRHAGE; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; GAMMA-AMINOBUTYRIC ACID; MALE; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 85052609725     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/3-211-30714-1_48     Document Type: Article

References (23)

1. Altar CA, Marien MR, Marshall JF (1987) Time course of adaptations in dopamine biosynthesis, metabolism, and release following nigrostriatal lesions: implications for behavioral recovery from brain injury. J Neurochem 48:390-399
2. Altar CA, O'Neil S, Marshall JF (1984) Sensorimotor impairment and elevated levels of dopamine metabolites in the neostriatum occur rapidly after intranigral injection of 6-hydroxydopamine or gamma-hydroxybutyrate in awake rats. Neuropharmacology 23:309-318
3. Broderick JP, Adams HP Jr, Barsan W, Feinberg W, Feldmann E, Grotta J, Kase C, Krieger D, Mayberg M, Tilley B, Zabramski JM, Zuccarello M (1999) Guidelines for the management of spontaneous intracerebral hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 30:905-915
4. Carreno-Muller E, Herrera AJ, de Pablos RM, Tomas-Camardiel M, Venero JL, Cano J, Machado A (2003) Thrombin induces in vivo degeneration of nigral dopaminergic neurones along with the activation of microglia. J Neurochem 84:1201-1214
5. Choi SH, Joe EH, Kim SU, Jin BK (2003) Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo. J Neurosci 23:5877-5886
6. Cicchetti F, Brownell AL, Williams K, Chen YI, Livni E, Isacson O (2002) Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur J Neurosci 15:991-998
7. Defer GL, Remy P, Malapert D, Ricolfi F, Samson Y, Degos JD (1994) Rest tremor and extrapyramidal symptoms after midbrain haemorrhage: clinical and 18F-dopa PET evaluation. J Neurol Neurosurg Psychiatry 57:987-989
8. Hua Y, Schallert T, Keep RF, Wu J, Hoff JT, Xi G (2002) Behavioral tests after intracerebral hemorrhage in the rat. Stroke 33:2478-2484
9. Inoue H, Udaka F, Takahashi M, Nishinaka K, Kameyama M (1997) Secondary parkinsonism following midbrain hemorrhage. Rinsho Shinkeigaku 37:266-269 [in Japanese]
10. Ling MJ, Aggarwal A, Morris JG (2002) Dopa-responsive parkinsonism secondary to right temporal lobe haemorrahage. Mov Disord 17:402-404
11. Manno EM, Atkinson JL, Fulgham JR, Wijdicks EF (2005) Emerging medical and surgical management strategies in the evaluation and treatment of intracerebral hemorrhage. Mayo Clin Proc 80:420-433
12. Matsuda W, Sugimoto K, Sato N, Watanabe T, Yanaka K, Matsumura A, Nose T (1999) A case of primary brain-stem injury recovered from persistent vegetative state after L-dopa administration. No To Shinkei 51:1071-1074 [in Japanese]
13. Muramatsu Y, Kurosaki R, Watanabe H, Michimata M, Matsubara M, Imai Y, Araki T (2003) Cerebral alterations in a MPTP-mouse model of Parkinson's disease - an immunocytochemical study. J Neural Transm 110:1129-1144
14. Nikolaus S, Larisch R, Beu M, Forutan F, Vosberg H, Muller-Gartner HW (2003) Bilateral increase in striatal dopamine D2 receptor density in the 6-hydroxydopamine-lesioned rat: a serial in vivo investigation with small animal PET. Eur J Nucl Med Mol Imaging 30:390-395
15. Olanow CW (2004) The scientific basis for the current treatment of Parkinson's disease. Annu Rev Med 55:41-60
16. Olanow CW, Tatton WG (1999) Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 22:123-144
17. Rowley HL, Martin KF, Marsden CA (1995) Determination of in vivo amino acid neurotransmitters by high-performance liquid chromatography with o-phthalaldehyde-sulphite derivatisation. J Neurosci Methods 57:93-99
18. Smith S, Sharp T (1994) Measurement of GABA in rat brain microdialysates using o-phthaldialdehyde-sulphite derivatization and high-performance liquid chromatography with electrochemical detection. J Chromatogr 652:228-233
19. Sparks DL, Slevin JT (1985) Determination of tyrosine, tryptophan and their metabolic derivatives by liquid chromatographyelectrochemical detection: application to post mortem samples from patients with Parkinson's and Alzheimer's disease. Life Sci 36:449-457
20. Wu J, Hua Y, Keep RF, Nakamura T, Hoff JT, Xi G (2003) Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke 34:2964-2969
21. Wu J, Hua Y, Keep RF, Schallert T, Hoff JT, Xi G (2002) Oxidative brain injury from extravasated erythrocytes after intracerebral hemorrhage. Brain Res 953:45-52
22. Xi G, Fewel ME, Hua Y, Thompson J, BG, Hoff JT, Keep RF (2004) Intracerebral hemorrhage: Pathophysiology and therapy. Neurocritical Care 1:5-18
23. Yuan H, Sarre S, Ebinger G, Michotte Y (2004) Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease. Brain Res 1026:95-107